{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:26:49Z","timestamp":1793406409326,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s10875-010-9423-4","type":"journal-article","created":{"date-parts":[[2010,5,7]],"date-time":"2010-05-07T06:06:20Z","timestamp":1273212380000},"page":"734-745","source":"Crossref","is-referenced-by-count":122,"title":["Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency"],"prefix":"10.1007","volume":"30","author":[{"given":"John B.","family":"Hagan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary B.","family":"Fasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon","family":"Spector","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Wasserman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Melamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail A.","family":"Rojavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Othmar","family":"Zenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan S.","family":"Orange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,8]]},"reference":[{"key":"9423_CR1","doi-asserted-by":"crossref","unstructured":"Primary immunodeficiency diseases: report of an IUIS Scientific Committee. Clin Exp Immunol. 1999;118:1\u201328.","DOI":"10.1046\/j.1365-2249.1999.00109.x"},{"key":"9423_CR2","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJM200011023431806","volume":"343","author":"RH Buckley","year":"2000","unstructured":"Buckley RH. Primary immunodeficiency diseases due to defects in lymphocytes. N Engl J Med. 2000;343:1313\u201324.","journal-title":"N Engl J Med"},{"key":"9423_CR3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2249.2003.02110.x","volume":"132","author":"H Chapel","year":"2003","unstructured":"Chapel H, Geha R, Rosen F. Primary immunodeficiency diseases: an update. Clin Exp Immunol. 2003;132:9\u201315.","journal-title":"Clin Exp Immunol"},{"key":"9423_CR4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","volume":"92","author":"C Cunningham-Rundles","year":"1999","unstructured":"Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92:34\u201348.","journal-title":"Clin Immunol"},{"key":"9423_CR5","volume-title":"Primary immunodeficiency diseases: a molecular and genetic approach","author":"HD Ochs","year":"2007","unstructured":"Ochs HD, Smith CIE, Puck JM. Primary immunodeficiency diseases: a molecular and genetic approach. Secondth ed. New York: Oxford University Press Inc, USA; 2007.","edition":"Second"},{"key":"9423_CR6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(08)61199-X","volume":"372","author":"MA Park","year":"2008","unstructured":"Park MA, Li JT, Hagan JB, Maddox DE, Abraham RS. Common variable immunodeficiency: a new look at an old disease. Lancet. 2008;372:489\u2013502.","journal-title":"Lancet"},{"key":"9423_CR7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.iac.2008.01.008","volume":"28","author":"M Berger","year":"2008","unstructured":"Berger M. Principles of and advances in immunoglobulin replacement therapy for primary immunodeficiency. Immunol Allergy Clin North Am. 2008;28:413\u201337.","journal-title":"Immunol Allergy Clin North Am"},{"key":"9423_CR8","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1067\/mai.2002.124999","volume":"109","author":"PJ Busse","year":"2002","unstructured":"Busse PJ, Razvi S, Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol. 2002;109:1001\u20134.","journal-title":"J Allergy Clin Immunol"},{"key":"9423_CR9","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1160\/TH03-10-0650","volume":"91","author":"JB Bussel","year":"2004","unstructured":"Bussel JB, Eldor A, Kelton JG, Varon D, Brenner B, Gillis S, et al. IGIV-C, a novel intravenous immunoglobulin: evaluation of safety, efficacy, mechanisms of action, and impact on quality of life. Thromb Haemost. 2004;91:771\u20138.","journal-title":"Thromb Haemost"},{"key":"9423_CR10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/pai.2009.0005","volume":"22","author":"JA Church","year":"2009","unstructured":"Church JA, Borte M, Taki H, Nelson RP, Sleasman JW, Knutsen AP, et al. Efficacy and safety of Privigen in children and adolescents with primary immunodeficiency. Pediatr Asthma Allergy Immunol. 2009;22:53\u201362.","journal-title":"Pediatr Asthma Allergy Immunol"},{"key":"9423_CR11","first-page":"745","volume":"4","author":"J Gracia de","year":"2004","unstructured":"de Gracia J, Vendrell M, Alvarez A, Pallisa E, Rodrigo MJ, de la RD, et al. Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency Int Immunopharmacol. 2004;4:745\u201353.","journal-title":"Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency. Int Immunopharmacol"},{"key":"9423_CR12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-135-3-200108070-00008","volume":"135","author":"HW Eijikhout","year":"2001","unstructured":"Eijikhout HW, van der Meer JW, Kallenberg CG, Weening RS, van Dissel JT, Sanders LA, et al. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial. Ann Intern Med. 2001;135:165\u201374.","journal-title":"Ann Intern Med"},{"key":"9423_CR13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0140-6736(91)90147-H","volume":"338","author":"A Gardulf","year":"1991","unstructured":"Gardulf A, Hammarstrom L, Smith CI. Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion. Lancet. 1991;338:162\u20136.","journal-title":"Lancet"},{"key":"9423_CR14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10875-008-9231-2","volume":"29","author":"MR Stein","year":"2009","unstructured":"Stein MR, Nelson RP, Church JA, Wasserman RL, Borte M, Vermylen C, et al. Safety and efficacy of Privigen\u00ae, a novel 10% liquid immunoglobulin preparation for intravenous use, in patients with primary immunodeficiencies. J Clin Immunol. 2009;29:137\u201344.","journal-title":"J Clin Immunol"},{"key":"9423_CR15","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1542\/peds.98.6.1127","volume":"98","author":"TG Abrahamsen","year":"1996","unstructured":"Abrahamsen TG, Sandersen H, Bustnes A. Home therapy with subcutaneous immunoglobulin infusions in children with congenital immunodeficiencies. Pediatrics. 1996;98:1127\u201331.","journal-title":"Pediatrics"},{"key":"9423_CR16","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.iac.2008.07.002","volume":"28","author":"M Berger","year":"2008","unstructured":"Berger M. Subcutaneous administration of IgG. Immunol Allergy Clin North Am. 2008;28:779\u2013802. viii.","journal-title":"Immunol Allergy Clin North Am"},{"key":"9423_CR17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1023\/A:1006678312925","volume":"20","author":"HM Chapel","year":"2000","unstructured":"Chapel HM, Spickett GP, Ericson D, Engl W, Eibl MM, Bjorkander J. The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy. J Clin Immunol. 2000;20:94\u2013100.","journal-title":"J Clin Immunol"},{"key":"9423_CR18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(95)90346-1","volume":"345","author":"A Gardulf","year":"1995","unstructured":"Gardulf A, Andersen V, Bjorkander J, Ericson D, Froland SS, Gustafson R, et al. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs. Lancet. 1995;345:365\u20139.","journal-title":"Lancet"},{"key":"9423_CR19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10875-006-9002-x","volume":"26","author":"A Gardulf","year":"2006","unstructured":"Gardulf A, Nicolay U, Asensio O, Bernatowska E, Bock A, Carvalho BC, et al. Rapid subcutaneous IgG replacement therapy is effective and safe in children and adults with primary immunodeficiencies\u2014a prospective, multi-national study. J Clin Immunol. 2006;26:177\u201385.","journal-title":"J Clin Immunol"},{"key":"9423_CR20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/01.all.0000246619.49494.41","volume":"6","author":"A Gardulf","year":"2006","unstructured":"Gardulf A, Nicolay U. Replacement IgG therapy and self-therapy at home improve the health-related quality of life in patients with primary antibody deficiencies. Curr Opin Allergy Clin Immunol. 2006;6:434\u201342.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"9423_CR21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/clim.2002.5215","volume":"104","author":"S Hansen","year":"2002","unstructured":"Hansen S, Gustafson R, Smith CI, Gardulf A. Express subcutaneous IgG infusions: decreased time of delivery with maintained safety. Clin Immunol. 2002;104:237\u201341.","journal-title":"Clin Immunol"},{"key":"9423_CR22","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0091-6749(98)70314-8","volume":"101","author":"ER Stiehm","year":"1998","unstructured":"Stiehm ER, Casillas AM, Finkelstein JZ, Gallagher KT, Groncy PM, Kobayashi RH, et al. Slow subcutaneous human intravenous immunoglobulin in the treatment of antibody immunodeficiency: use of an old method with a new product. J Allergy Clin Immunol. 1998;101:848\u20139.","journal-title":"J Allergy Clin Immunol"},{"key":"9423_CR23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF00915353","volume":"3","author":"MJ Welch","year":"1983","unstructured":"Welch MJ, Stiehm ER. Slow subcutaneous immunoglobulin therapy in a patient with reactions to intramuscular immunoglobulin. J Clin Immunol. 1983;3:285\u20136.","journal-title":"J Clin Immunol"},{"key":"9423_CR24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.biologicals.2008.01.004","volume":"36","author":"M Stucki","year":"2008","unstructured":"Stucki M, Boschetti N, Schaefer W, Hostettler T, Kaesermann F, Nowak T, et al. Investigations of prion and virus safety of a new liquid IVIG product. Biologicals. 2008;36:239\u201347.","journal-title":"Biologicals"},{"key":"9423_CR25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10875-006-9021-7","volume":"26","author":"HD Ochs","year":"2006","unstructured":"Ochs HD, Gupta S, Kiessling P, Nicolay U, Berger M. Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases. J Clin Immunol. 2006;26:265\u201373.","journal-title":"J Clin Immunol"},{"key":"9423_CR26","unstructured":"FDA. Safety, efficacy, and pharmacokinetic studies to support marketing of immune globulin intravenous (human) as replacement therapy for primary humoral immunodeficiency. Guidance for industry; 2008."},{"key":"9423_CR27","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0022-3476(99)70246-5","volume":"134","author":"P Quartier","year":"1999","unstructured":"Quartier P, Debre M, De Blic J, de Sauverzac R, Sayegh N, Jabado N, et al. Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients. J Pediatr. 1999;134:589\u201396.","journal-title":"J Pediatr"},{"key":"9423_CR28","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s10875-006-9025-3","volume":"26","author":"JA Church","year":"2006","unstructured":"Church JA, Leibl H, Stein MR, Melamed IR, Rubinstein A, Schneider LC, et al. Efficacy, safety and tolerability of a new 10% liquid intravenous immune globulin [IGIV 10%] in patients with primary immunodeficiency. J Clin Immunol. 2006;26:388\u201395.","journal-title":"J Clin Immunol"},{"key":"9423_CR29","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S1567-5769(03)00134-6","volume":"3","author":"CM Roifman","year":"2003","unstructured":"Roifman CM, Schroeder H, Berger M, Sorensen R, Ballow M, Buckley RH, et al. Comparison of the efficacy of IGIV-C, 10% (caprylate\/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trial Int Immunopharmacol. 2003;3:1325\u201333.","journal-title":"A randomized double-blind trial. Int Immunopharmacol"},{"key":"9423_CR30","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1081-1206(10)60388-2","volume":"99","author":"S Dave","year":"2007","unstructured":"Dave S, Hagan J. Myocardial infarction during intravenous immunoglobulin infusion in a 65-year-old man with common variable immunodeficiency and subsequent successful repeated administration. Ann Allergy Asthma Immunol. 2007;99:567\u201370.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"9423_CR31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00415-009-0969-0","volume":"256","author":"JB Caress","year":"2009","unstructured":"Caress JB, Hobson-Webb L, Passmore LV, Finkbiner AP, Cartwright MS. Case-control study of thromboembolic events associated with IV immunoglobulin. J Neurol. 2009;256:339\u201342.","journal-title":"J Neurol"},{"key":"9423_CR32","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0091-6749(03)01780-9","volume":"112","author":"HC Brown","year":"2003","unstructured":"Brown HC, Ballas ZK. Acute thromboembolic events associated with intravenous immunoglobulin infusion in antibody-deficient patients. J Allergy Clin Immunol. 2003;112:797\u20139.","journal-title":"J Allergy Clin Immunol"},{"key":"9423_CR33","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/00006454-199707000-00012","volume":"16","author":"ER Stiehm","year":"1997","unstructured":"Stiehm ER. Human intravenous immunoglobulin in primary and secondary antibody deficiencies. Pediatr Infect Dis J. 1997;16:696\u2013707.","journal-title":"Pediatr Infect Dis J"},{"key":"9423_CR34","unstructured":"European Agency for the Evaluation of Medicinal Products (EMEA), Committee for Proprietary Medicinal Products (CPMP). Note for guidance on the clinical investigation of human normal immunoglobulin for subcutaneous and intramuscular use. EMEA\/CPMP\/BPWG\/283\/00; 2002"},{"key":"9423_CR35","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s10875-006-9031-5","volume":"26","author":"JM Kittner","year":"2006","unstructured":"Kittner JM, Grimbacher B, Wulff W, Jager B, Schmidt RE. Patients' attitude to subcutaneous immunoglobulin substitution as home therapy. J Clin Immunol. 2006;26:400\u20135.","journal-title":"J Clin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10875-010-9423-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T02:32:05Z","timestamp":1685586725000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-010-9423-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,8]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["9423"],"URL":"https:\/\/doi.org\/10.1007\/s10875-010-9423-4","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,8]]}}}